Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. S 1108
2. S-1108
1. 105889-45-0
2. Cefcapene Piroxil
3. Cefcapene-pivoxil
4. Flomox
5. 8i8mj56xfq
6. 2,2-dimethylpropanoyloxymethyl (6r,7r)-7-[[(z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino]-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
7. S-1108
8. Cefcamate Pivoxil
9. Unii-8i8mj56xfq
10. 2,2-dimethylpropanoyloxymethyl (6r,7r)-7-(((z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl)amino)-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
11. Schembl155121
12. Schembl155122
13. Chembl2431072
14. Dtxsid7049134
15. Cefcapene Pivoxil [who-dd]
16. Zinc3924558
17. Akos015841961
18. Akos015896113
19. Hy-135221a
20. Cefcapene Pivaloyloxymethyl Ester
21. As-12938
22. Cs-0111083
23. Cefcapene Pivaloyloxymethyl Ester [mi]
24. 889c450
25. A801331
26. Q27270575
27. 2,2-dimethylpropanoyloxymethyl (6r,7r)-7-[[(z)-2-(2-aminothiazol-4-yl)pent-2-enoyl]amino]-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;cefcapene Pivoxil
28. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-(((2z)-2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (6r,7r)-
29. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (6r-(6alpha,7beta(z)))-
Molecular Weight | 567.6 g/mol |
---|---|
Molecular Formula | C23H29N5O8S2 |
XLogP3 | 1.5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 13 |
Exact Mass | 567.14575525 g/mol |
Monoisotopic Mass | 567.14575525 g/mol |
Topological Polar Surface Area | 247 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 1060 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
97
PharmaCompass offers a list of Cefcapene Pivoxil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefcapene Pivoxil manufacturer or Cefcapene Pivoxil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefcapene Pivoxil manufacturer or Cefcapene Pivoxil supplier.
PharmaCompass also assists you with knowing the Cefcapene Pivoxil API Price utilized in the formulation of products. Cefcapene Pivoxil API Price is not always fixed or binding as the Cefcapene Pivoxil Price is obtained through a variety of data sources. The Cefcapene Pivoxil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fumax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fumax, including repackagers and relabelers. The FDA regulates Fumax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fumax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fumax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fumax supplier is an individual or a company that provides Fumax active pharmaceutical ingredient (API) or Fumax finished formulations upon request. The Fumax suppliers may include Fumax API manufacturers, exporters, distributors and traders.
click here to find a list of Fumax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fumax Drug Master File in Japan (Fumax JDMF) empowers Fumax API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fumax JDMF during the approval evaluation for pharmaceutical products. At the time of Fumax JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fumax suppliers with JDMF on PharmaCompass.
Fumax Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fumax GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fumax GMP manufacturer or Fumax GMP API supplier for your needs.
A Fumax CoA (Certificate of Analysis) is a formal document that attests to Fumax's compliance with Fumax specifications and serves as a tool for batch-level quality control.
Fumax CoA mostly includes findings from lab analyses of a specific batch. For each Fumax CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fumax may be tested according to a variety of international standards, such as European Pharmacopoeia (Fumax EP), Fumax JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fumax USP).